Shannon Fogh

Summary

Affiliation: Thomas Jefferson University Hospital
Country: USA

Publications

  1. ncbi Use of tamoxifen with postsurgical irradiation may improve survival in estrogen and progesterone receptor-positive male breast cancer
    Shannon Fogh
    Department of Radiation Oncology, Boston University Medical Center, USA
    Clin Breast Cancer 11:39-45. 2011
  2. ncbi Phase I trial using the proteasome inhibitor bortezomib and concurrent chemoradiotherapy for head-and-neck malignancies
    Gregory J Kubicek
    Department of Radiation Oncology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA, USA
    Int J Radiat Oncol Biol Phys 83:1192-7. 2012
  3. ncbi A comparison of preplan transrectal ultrasound with preplan-CT in assessing volume and number of seeds needed for real-time ultrasound-based intra-operative planning in prostate (125)I seed implantation
    Shannon Fogh
    Department of Radiation Oncology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA
    Brachytherapy 9:335-40. 2010
  4. ncbi Shot sequencing based on biological equivalent dose considerations for multiple isocenter Gamma Knife radiosurgery
    Lijun Ma
    Department of Radiation Oncology, University of California, San Francisco, CA 94143, USA
    Phys Med Biol 56:7247-56. 2011
  5. ncbi Phase I trial using patupilone (epothilone B) and concurrent radiotherapy for central nervous system malignancies
    Shannon Fogh
    Department of Radiation Oncology, Jefferson Medical College of Thomas Jefferson University, Philadelphia, PA 19107, USA
    Int J Radiat Oncol Biol Phys 77:1009-16. 2010
  6. ncbi Multiple courses of stereotactic re-irradiation in recurrent oligodendroglioma: a case report
    Shannon Fogh
    Department of Radiation Oncology, University of California San Francisco, 505 Parnassus Ave, Room L 08, Box 0226, San Francisco, CA 94143, USA
    J Med Case Reports 5:183. 2011

Detail Information

Publications6

  1. ncbi Use of tamoxifen with postsurgical irradiation may improve survival in estrogen and progesterone receptor-positive male breast cancer
    Shannon Fogh
    Department of Radiation Oncology, Boston University Medical Center, USA
    Clin Breast Cancer 11:39-45. 2011
    ..The purpose of this study is to assess the impact of adjuvant therapy on survival in males with non-metastatic breast cancer...
  2. ncbi Phase I trial using the proteasome inhibitor bortezomib and concurrent chemoradiotherapy for head-and-neck malignancies
    Gregory J Kubicek
    Department of Radiation Oncology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA, USA
    Int J Radiat Oncol Biol Phys 83:1192-7. 2012
    ..This Phase I dose-escalation study examined the potential of bortezomib in combination with cisplatin chemotherapy and concurrent radiation in the treatment of locally advanced and recurrent HNC...
  3. ncbi A comparison of preplan transrectal ultrasound with preplan-CT in assessing volume and number of seeds needed for real-time ultrasound-based intra-operative planning in prostate (125)I seed implantation
    Shannon Fogh
    Department of Radiation Oncology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA
    Brachytherapy 9:335-40. 2010
    ....
  4. ncbi Shot sequencing based on biological equivalent dose considerations for multiple isocenter Gamma Knife radiosurgery
    Lijun Ma
    Department of Radiation Oncology, University of California, San Francisco, CA 94143, USA
    Phys Med Biol 56:7247-56. 2011
    ....
  5. ncbi Phase I trial using patupilone (epothilone B) and concurrent radiotherapy for central nervous system malignancies
    Shannon Fogh
    Department of Radiation Oncology, Jefferson Medical College of Thomas Jefferson University, Philadelphia, PA 19107, USA
    Int J Radiat Oncol Biol Phys 77:1009-16. 2010
    ....
  6. ncbi Multiple courses of stereotactic re-irradiation in recurrent oligodendroglioma: a case report
    Shannon Fogh
    Department of Radiation Oncology, University of California San Francisco, 505 Parnassus Ave, Room L 08, Box 0226, San Francisco, CA 94143, USA
    J Med Case Reports 5:183. 2011
    ..abstract:..